$38.27
$-0.53 (-1.37%)
End-of-day quote: 05/14/2024
NasdaqGS:IONS
Ionis Pharmaceuticals Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| AMGN | Amgen | NasdaqGS | Outperform | $311.41 | $303.65 | 0.00% | 8 | $167.05B |
| PFE | Pfizer | NYSE | Outperform | $28.38 | $32.87 | 0.00% | 6 | $160.82B |
| SAN | Sanofi | ENXTPA | Outperform | 91.69€ | 102.80€ | 0.00% | 9 | 114.49€B |
| REGN | Regeneron Pharmaceuticals | NasdaqGS | Outperform | $984.64 | $961.26 | 0.00% | 8 | $106.23B |
| CSL | CSL | ASX | Outperform | $279.58 | $205.51 | 0.00% | 5 | $135.11B |
| 4568 | Daiichi Sankyo Company | TSE | Buy | ¥5.42k | ¥5.24k | 0.00% | 0 | ¥10.38T |
| MRNA | Moderna | NasdaqGS | Outperform | $128.32 | $135.42 | 0.00% | 1 | $49.18B |
| 4502 | Takeda Pharmaceutical Company | TSE | Outperform | ¥4.21k | ¥4.74k | 0.00% | 0 | ¥6.60T |
| BIIB | Biogen | NasdaqGS | Outperform | $226.88 | $299.62 | 0.00% | 13 | $33.03B |
| ALNY | Alnylam Pharmaceuticals Inc | NASDAQ | Outperform | $147.89 | $245.24 | 0.00% | 7 | $18.71B |
| BMRN | BioMarin Pharmaceutical | NasdaqGS | Outperform | $79.65 | $111.56 | 0.00% | 5 | $15.39B |
| SRPT | Sarepta Therapeutics | NasdaqGS | Outperform | $132.66 | $158.66 | 0.00% | 6 | $12.51B |
| INCY | Incyte | NasdaqGS | Outperform | $57.05 | $77.05 | 0.00% | 8 | $12.01B |
| JAZZ | Jazz Pharmaceuticals | NasdaqGS | Outperform | $112.01 | $188.32 | 0.00% | 4 | $7.13B |
| EXEL | Exelixis | NasdaqGS | Outperform | $20.99 | $26.44 | 0.00% | 5 | $6.34B |
| NTLA | Intellia Therapeutics | NasdaqGM | Outperform | $25.73 | $75.84 | 0.00% | 21 | $2.36B |
| DYN | Dyne Therapeutics | NasdaqGS | Buy | $28.16 | $28.13 | 0.00% | 0 | $2.27B |
| DCPH | Deciphera Pharmaceuticals | NasdaqGS | Hold | $25.44 | $23.40 | 0.00% | 4 | $2.19B |
| 4516 | Nippon Shinyaku | TSE | Outperform | ¥3.88k | ¥8.34k | 0.00% | 0 | ¥261.33B |
| BCRX | BioCryst Pharmaceuticals | NasdaqGS | Outperform | $5.36 | $14.09 | 0.00% | 2 | $1.09B |
| WVE | Wave Life Sciences | NasdaqGM | Outperform | $5.84 | $9.21 | 0.00% | 3 | $688.23M |
| PHARM | Pharming Group N.V. | ENXTAM | Buy | 0.87€ | 1.85€ | 0.00% | 2 | 591.95€M |
| STOK | Stoke Therapeutics | NasdaqGS | Buy | $12.80 | $19.33 | 0.00% | 3 | $604.59M |
| ABUS | Arbutus Biopharma | NasdaqGS | Outperform | $2.86 | $6.34 | 0.00% | 0 | $535.96M |
| KALV | KalVista Pharmaceuticals | NasdaqGM | Buy | $12.49 | $20.80 | 0.00% | 0 | $478.84M |
| FULC | Fulcrum Therapeutics | NasdaqGM | Outperform | $7.91 | $10.21 | 0.00% | 7 | $456.83M |
| PYC | PYC Therapeutics | ASX | Buy | $0.10 | $0.30 | 0.00% | 1 | $294.90M |
